Sorrento Therapeutics (SRNE)

Sorrento Therapeutics (SRNE) Financial Statements


Sorrento Therapeutics Financial Overview

Sorrento Therapeutics's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Sorrento Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement-
Total Revenue$ 17.40M$ 11.46M$ 18.39M$ 13.08M$ 12.06M
Gross Profit$ 9.13M$ 5.76M$ 12.63M$ 9.94M$ 8.68M
EBIT$ -90.91M$ -218.28M$ -35.70M$ -175.13M$ -116.87M
EBITDA$ -87.55M$ -215.05M$ -32.40M$ -172.27M$ -113.33M
Net Income Common Stockholders$ -89.58M$ -218.76M$ -40.81M$ -144.42M$ -119.80M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 117.86M$ 133.60M$ 270.66M$ 126.88M$ 162.67M
Total Assets$ 615.61M$ 632.13M$ 855.64M$ 694.82M$ 752.79M
Total Debt$ 168.21M$ 204.61M$ 248.88M$ 237.58M$ 202.56M
Net Debt$ 50.35M$ 71.00M$ -21.77M$ 110.69M$ 39.89M
Total Liabilities$ 485.41M$ 496.37M$ 629.44M$ 616.69M$ 621.46M
Stockholders Equity$ 131.85M$ 132.02M$ 226.54M$ 78.75M$ 131.50M
Cash Flow-
Free Cash Flow$ -65.01M$ -83.69M$ -85.95M$ -74.35M$ -84.29M
Operating Cash Flow$ -61.17M$ -80.99M$ -83.36M$ -72.14M$ -83.11M
Investing Cash Flow$ -8.09M$ -1.73M$ -13.66M$ -2.21M$ 5.40M
Financing Cash Flow$ 71.50M$ 41.77M$ 173.37M$ 70.86M$ 40.06M
Currency in USD

Sorrento Therapeutics Earnings and Revenue History

Sorrento Therapeutics Debt to Assets

Sorrento Therapeutics Cash Flow

Sorrento Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis